FDA Adverse Event Malfunction Summary report: N

UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM

MDR report key: 2160275 · Received June 2, 2011

Report

Report Number
2122870-2011-01613
Event Type
Malfunction
Date Received
June 2, 2011
Date of Event
July 30, 2007
Report Date
July 30, 2007
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K023764
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS NOT DISPATCHED AS THE ISSUE WAS ISOLATED TO ONE PATIENT AND RESULTS WERE ABLE TO BE REPRODUCED. THE CUSTOMER STATED TROPONIN RESULTS WERE ELEVATED BUT DID NOT PROVIDE EXACT VALUES. THE CUSTOMER REPORTED VALUES OBTAINED WERE NEAR 27 NG/ML. THE CUSTOMER STATED, THE SAMPLES FROM THIS PATIENT WERE TESTED AND WERE NEGATIVE ON THE ISTAT AND CENTAUR METHODS. SAMPLE HANDLING DETAILS AND QUALITY CONTROL (QC) DATA WERE NOT SUPPLIED. THE CUSTOMER PROVIDED SAMPLES TO BECKMAN COULTER, INC. FOR FURTHER INVESTIGATION CONSISTING OF ONE SERUM, TWO PLASMA, AND ONE WHOLE BLOOD SPECIMEN. THE SERUM AND PLASMA SAMPLES WERE TESTED IN THE CUSTOMER PRODUCT LINE SUPPORT (CPLS) LABORATORY. CPLS TESTED THE SAMPLES NEAT AND REPRODUCED THE ELEVATED VALUES. FURTHERMORE, THE ADDITION OF HETEROPHILE BLOCKING AGENTS SIGNIFICANTLY REDUCED THE TROPONIN CONCENTRATION, WHICH CONFIRMS HETEROPHILE INTERFERENCE IS THE ROOT CAUSE FOR THE ERRONEOUS, FALSE POSITIVE TROPONIN RESULTS. PRODUCT LABELING: FOR ASSAYS EMPLOYING MOUSE ANTIBODIES, THE POSSIBILITY EXISTS FOR INTERFERENCE BY HUMAN ANTI-MOUSE ANTIBODIES (HAMA) IN THE SAMPLE. HUMAN ANTI-MOUSE ANTIBODIES MAY BE PRESENT IN SAMPLES FROM PATIENTS WHO HAVE RECEIVED IMMUNOTHERAPY OR DIAGNOSTIC PROCEDURES UTILIZING MONOCLONAL ANTIBODIES OR IN INDIVIDUALS WHO HAVE BEEN REGULARLY EXPOSED TO ANIMALS. ADDITIONALLY, OTHER HETEROPHILE ANTIBODIES, SUCH AS HUMAN ANTI-GOAT ANTIBODIES, MAY BE PRESENT IN PATIENT SAMPLES. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF PRODUCT COMPLAINTS CONDUCTED BETWEEN (B)(6) 2008 TO (B)(6), 2010 FOR ADDITIONAL REPORTABLE EVENTS.

Description of Event or Problem · 1

THE CUSTOMER REPORTED ELEVATED TROPONIN (ACCUTNI) PATIENT RESULTS INVOLVING UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM. RESULTS WERE REPEATEDLY ABOVE THE ACUTE MYOCARDIAL INFARCTION (AMI) CUTOFF AND NEGATIVE BY TWO ADDITIONAL METHODS. THE CUSTOMER TESTED THIS PATIENT SAMPLE ON THE DXI AND ACCESS 2 SYSTEMS AS WELL AS ON ANOTHER ACCESS 2 UNIT AT THE HOSPITAL SITE WHERE THE PATIENT WAS LOCATED. THE CUSTOMER HAD ALSO SENT OUT SAMPLES TO BE TESTED BY A THIRD LABORATORY THAT USES A CENTAUR SYSTEM, AND THE PATIENT RESULTS CAME BACK NORMAL. THE CUSTOMER NOTED, THE PATIENT HAD A NORMAL ELECTROCARDIOGRAM (ECG). THE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. IT WAS NOTED THAT THERE WAS A CHANGE IN PATIENT TREATMENT BUT THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ATTRIBUTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK ACCESS 2 IMMUNOASSAY SYSTEM| ACCUTNI ON THE ACCESS IMMUNOASSAY SYSTEMS